Suchergebnisse - "Goto, Yasushi"

PubPharm (273)

1

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01) : primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Smit, E. | Felip, E. | Uprety, D. | +17

2

Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis : a propensity-matched real-world analysis

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tamura, K. | Okuma, Y. | Nomura, S. | +9

3

Efficacy and safety of chemoimmunotherapy in advanced non-small cell lung cancer patients with antibiotics-induced dysbiosis: a propensity-matched real-world analysis

enthalten in: Journal of cancer research and clinical oncology | 2024

von Tamura, K. | Okuma, Y. | Nomura, S. | +9

4

Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Miyakoshi, J. | Yoshida, T. | Kashima, J. | +14

5

CONTACT-01 : A Randomized Phase III Trial of Atezolizumab + Cabozantinib Versus Docetaxel for Metastatic Non-Small Cell Lung Cancer After a Checkpoint Inhibitor and Chemotherapy

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2024

von Neal, J. | Pavlakis, N. | Kim, S. | +19

6

Prognostic significance of ground-glass areas within tumours in non-small-cell lung cancer

enthalten in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery | 2024

von Sakurai, H. | Goto, Y. | Yoh, K. | +9

7

Improved Outcomes in Resectable Advanced or Recurrent Lung Cancer

enthalten in: Gan to kagaku ryoho. Cancer & chemotherapy | 2024

von Goto, Y.

8

Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial)

enthalten in: Japanese journal of clinical oncology | 2024

von Tsukita, Y. | Taguri, M. | Goto, Y. | +7

9

Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study

enthalten in: JTO clinical and research reports | 2024

von Teraoka, S. | Hayashi, H. | Goto, Y. | +8

10

A pragmatic guide for management of adverse events associated with lorlatinib

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Liu, G. | Mazieres, J. | Stratmann, J. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[28]